+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heron Therapeutics, Inc. - logo

Heron Therapeutics is a biotechnology company that develops medicines to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer drug delivery technology, which can deliver therapeutic levels of a wide range of otherwise short-acting pharmacological agents over a period of days to weeks with a single injection. Its product portfolio includes SUSTOL, CINVANTI (HTX-019) and HTX-011. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.

CINV Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

CINV Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Global Cancer Supportive Care Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Cancer Supportive Care Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 177 Pages
  • Global
From
Postoperative Pain - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Postoperative Pain - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2022
  • 324 Pages
  • Global
From
CINV Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

CINV Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 121 Pages
  • Global
From
Post-Operative Pain - Pipeline Review, H2 2020 - Product Thumbnail Image

Post-Operative Pain - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 302 Pages
  • Global
From
Inguinal Hernia Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Inguinal Hernia Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 153 Pages
  • Global
From
Heron Therapeutics Inc (HRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Heron Therapeutics Inc (HRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Comprehensive Report on Heron Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Heron Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2023
  • 57 Pages
From
Loading Indicator